Pancreatitis Explained

Pancreatitis
Complications:Infection, bleeding, diabetes mellitus, pancreatic cancer, kidney failure, breathing problems, malnutrition[1]
Duration:Short or long term
Risks:Smoking
Diagnosis:Based on symptoms, blood amylase or lipase
Treatment:Intravenous fluids, pain medication, antibiotics
Frequency:8.9 million (2015)
Deaths:132,700 (2015)

Pancreatitis is a condition characterized by inflammation of the pancreas. The pancreas is a large organ behind the stomach that produces digestive enzymes and a number of hormones. There are two main types: acute pancreatitis, and chronic pancreatitis.

Signs and symptoms of pancreatitis include pain in the upper abdomen, nausea and vomiting. The pain often goes into the back and is usually severe. In acute pancreatitis, a fever may occur; symptoms typically resolve in a few days. In chronic pancreatitis weight loss, fatty stool, and diarrhea may occur.[2] Complications may include infection, bleeding, diabetes mellitus, or problems with other organs.[3]

The two most common causes of acute pancreatitis are a gallstone blocking the common bile duct after the pancreatic duct has joined; and heavy alcohol use.[3] Other causes include direct trauma, certain medications, infections such as mumps, and tumors.[3] Chronic pancreatitis may develop as a result of acute pancreatitis.[3] It is most commonly due to many years of heavy alcohol use.[3]

Other causes include high levels of blood fats, high blood calcium, some medications, and certain genetic disorders, such as cystic fibrosis, among others.[3] Smoking increases the risk of both acute and chronic pancreatitis.[4] Diagnosis of acute pancreatitis is based on a threefold increase in the blood of either amylase or lipase.[3] In chronic pancreatitis, these tests may be normal.[3] Medical imaging such as ultrasound and CT scan may also be useful.[3]

Acute pancreatitis is usually treated with intravenous fluids, pain medication, and sometimes antibiotics.[3] Typically eating and drinking are disallowed, and a nasogastric tube is placed in the stomach.[3] A procedure known as an endoscopic retrograde cholangiopancreatography (ERCP) may be done to examine the distal common bile duct and remove a gallstone if present.[3] In those with gallstones the gallbladder is often also removed.[3] In chronic pancreatitis, in addition to the above, temporary feeding through a nasogastric tube may be used to provide adequate nutrition.[3] Long-term dietary changes and pancreatic enzyme replacement may be required.[3] Occasionally, surgery is done to remove parts of the pancreas.[3]

Globally, in 2015 about 8.9 million cases of pancreatitis occurred.[5] This resulted in 132,700 deaths, up from 83,000 deaths in 1990.[6] [7] Acute pancreatitis occurs in about 30 per 100,000 people a year.[8] New cases of chronic pancreatitis develop in about 8 per 100,000 people a year and currently affect about 50 per 100,000 people in the United States. It is more common in men than women.[3] Often chronic pancreatitis starts between the ages of 30 and 40 and is rare in children.[3] Acute pancreatitis was first described on autopsy in 1882 while chronic pancreatitis was first described in 1946.[9]

Signs and symptoms

The most common symptoms of pancreatitis are severe upper abdominal or left upper quadrant burning pain radiating to the back, nausea, and vomiting that is worse with eating. The physical examination will vary depending on severity and presence of internal bleeding. Blood pressure may be elevated by pain or decreased by dehydration or bleeding. Heart and respiratory rates are often elevated. The abdomen is usually tender but to a lesser degree than the pain itself. As is common in abdominal disease, bowel sounds may be reduced from reflex bowel paralysis. Fever or jaundice may be present. Chronic pancreatitis can lead to diabetes or pancreatic cancer. Unexplained weight loss may occur from a lack of pancreatic enzymes hindering digestion.

Complications

Early complications include shock, infection, systemic inflammatory response syndrome, low blood calcium, high blood glucose, and dehydration. Blood loss, dehydration, and fluid leaking into the abdominal cavity (ascites) can lead to kidney failure. Respiratory complications are often severe. Pleural effusion is usually present. Shallow breathing from pain can lead to lung collapse. Pancreatic enzymes may attack the lungs, causing inflammation. Severe inflammation can lead to intra-abdominal hypertension and abdominal compartment syndrome, further impairing renal and respiratory function and potentially requiring management with an open abdomen to relieve the pressure.[10]

Late complications include recurrent pancreatitis and the development of pancreatic pseudocysts—collections of pancreatic secretions that have been walled off by scar tissue. These may cause pain, become infected, rupture and bleed, block the bile duct and cause jaundice, or migrate around the abdomen. Acute necrotizing pancreatitis can lead to a pancreatic abscess, a collection of pus caused by necrosis, liquefaction, and infection. This happens in approximately 3% of cases or almost 60% of cases involving more than two pseudocysts and gas in the pancreas.

Causes

Eighty percent of cases of pancreatitis are caused by alcohol or gallstones. Gallstones are the single most common cause of acute pancreatitis.[11] Alcohol is the single most common cause of chronic pancreatitis.[12] [13] [14] [15] [16] Triglyceride levels greater than 1000 mg/dL (11.29 mmol/L) is another cause.[17]

Medications

There are seven classes of medications associated with acute pancreatitis: statins, ACE inhibitors, oral contraceptives/hormone replacement therapy (HRT), diuretics, antiretroviral therapy, valproic acid, and oral hypoglycemic agents. Mechanisms of these drugs causing pancreatitis are not known exactly, but it is possible that statins have direct toxic effect on the pancreas or through the long-term accumulation of toxic metabolites. Meanwhile, ACE inhibitors cause angioedema of the pancreas through the accumulation of bradykinin. Birth control pills and HRT cause arterial thrombosis of the pancreas through the accumulation of fat (hypertriglyceridemia). Diuretics such as furosemide have a direct toxic effect on the pancreas. Meanwhile, thiazide diuretics cause hypertriglyceridemia and hypercalcemia, where the latter is the risk factor for pancreatic stones.

HIV infection itself can cause a person to be more likely to get pancreatitis. Meanwhile, antiretroviral drugs may cause metabolic disturbances such as hyperglycemia and hypercholesterolemia, which predisposes to pancreatitis. Valproic acid may have direct toxic effect on the pancreas.[18] Various oral hypoglycemic agents are associated with pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated with pancreatitis by promoting inflammation in combination with a high-fat diet.[19]

Atypical antipsychotics such as clozapine, risperidone, and olanzapine can also cause pancreatitis.[20]

Infection

A number of infectious agents have been recognized as causes of pancreatitis including:[21] [22] [23]

Other

Other common causes include trauma, autoimmune disease, high blood calcium, hypothermia, and endoscopic retrograde cholangiopancreatography (ERCP). Pancreas divisum is a common congenital malformation of the pancreas that may underlie some recurrent cases. Diabetes mellitus type 2 is associated with a 2.8-fold higher risk.[24]

Less common causes include pancreatic cancer, pancreatic duct stones,[25] vasculitis (inflammation of the small blood vessels in the pancreas), and porphyria—particularly acute intermittent porphyria and erythropoietic protoporphyria.

There is an inherited form that results in the activation of trypsinogen within the pancreas, leading to autodigestion. Involved genes may include trypsin 1, which codes for trypsinogen, SPINK1, which codes for a trypsin inhibitor, or cystic fibrosis transmembrane conductance regulator.[26]

The mnemonic GETSMASHED is often used to remember the common causes of pancreatitis: G—gallstones, E—ethanol, T—trauma, S—steroids, M—mumps, A—autoimmune pancreatitis, S—scorpion sting, H—hyperlipidemia, hypothermia, hyperparathyroidism, E—endoscopic retrograde cholangiopancreatography, D—drugs (commonly azathioprine, valproic acid, liraglutide).[27]

Diagnosis

The differential diagnosis for pancreatitis includes but is not limited to cholecystitis, choledocholithiasis, perforated peptic ulcer, bowel infarction, small bowel obstruction, hepatitis, and mesenteric ischemia.[28]

Diagnosis requires 2 of the 3 following criteria:

Amylase and lipase are 2 enzymes produced by the pancreas. Elevations in lipase are generally considered a better indicator for pancreatitis as it has greater specificity and has a longer half life. However, both enzymes can be elevated in other disease states. In chronic pancreatitis, the fecal pancreatic elastase-1 (FPE-1) test is a marker of exocrine pancreatic function. Additional tests that may be useful in evaluating chronic pancreatitis include hemoglobin A1C, immunoglobulin G4, rheumatoid factor, and anti-nuclear antibody.[29]

For imaging, abdominal ultrasound is convenient, simple, non-invasive, and inexpensive.[30] It is more sensitive and specific for pancreatitis from gallstones than other imaging modalities.[31] However, in 25–35% of patients the view of the pancreas can be obstructed by bowel gas making it difficult to evaluate.

A contrast-enhanced CT scan is usually performed more than 48 hours after the onset of pain to evaluate for pancreatic necrosis and extrapancreatic fluid as well as predict the severity of the disease. CT scanning earlier can be falsely reassuring.[32]

ERCP or an endoscopic ultrasound can also be used if a biliary cause for pancreatitis is suspected.

Treatment

The treatment of pancreatitis is supportive and depends on severity. Morphine generally is suitable for pain control. There are no clinical studies to suggest that morphine can aggravate or cause pancreatitis or cholecystitis.[33]

The treatment for acute pancreatitis will depend on whether the diagnosis is for the mild form of the condition, which causes no complications, or the severe form, which can cause serious complications.

Mild acute pancreatitis

The treatment of mild acute pancreatitis is successfully carried out by admission to a general hospital ward. Traditionally, people were not allowed to eat until the inflammation resolved but more recent evidence suggests early feeding is safe and improves outcomes, and may result in an ability to leave the hospital sooner.[34]

Due to inflammation occurring in pancreatitis, proinflammatory cytokines secreted into the bloodstream can cause inflammation throughout the body, including the lungs and can manifest as ARDS. Because pancreatitis can cause lung injury and affect normal lung function, supplemental oxygen is occasionally delivered through breathing tubes that are connected via the nose (e.g., nasal cannulae) or via a mask. The tubes can then be removed after a few days once it is clear that the condition is improving.

Dehydration may result during an episode of acute pancreatitis, so fluids will be provided intravenously.

Opioids may be used for the pain. When the pancreatitis is due to gallstones, early gallbladder removal also appears to improve outcomes.[35]

Severe acute pancreatitis

Severe pancreatitis can cause organ failure, necrosis, infected necrosis, pseudocyst, and abscess. If diagnosed with severe acute pancreatitis, people will need to be admitted to a high-dependency unit or intensive care unit. It is likely that the levels of fluids inside the body will have dropped significantly as it diverts bodily fluids and nutrients in an attempt to repair the pancreas. The drop in fluid levels can lead to a reduction in the volume of blood within the body, which is known as hypovolemic shock. Hypovolemic shock can be life-threatening as it can very quickly starve the body of the oxygen-rich blood that it needs to survive. To avoid going into hypovolemic shock, fluids will be administered intravenously. Oxygen will be supplied through tubes attached to the nose and ventilation equipment may be used to assist with breathing. Feeding tubes may be used to provide nutrients, combined with appropriate analgesia.

As with mild pancreatitis, it will be necessary to treat the underlying cause—gallstones, discontinuing medications, cessation of alcohol, etc. If the cause is gallstones, it is likely that an ERCP procedure or removal of the gallbladder will be recommended. The gallbladder should be removed during the same hospital admission or within two weeks of pancreatitis onset so as to limit the risk of recurrent pancreatitis.

If the cause of pancreatitis is alcohol, cessation of alcohol consumption and treatment for alcohol dependency may improve pancreatitis. Even if the underlying cause is not related to alcohol consumption, doctors recommend avoiding it for at least six months as this can cause further damage to the pancreas during the recovery process.[36]

Oral intake, especially fats, is generally restricted initially but early enteral feeding within 48 hours has been shown to improve clinical outcomes.[37] Fluids and electrolytes are replaced intravenously. Nutritional support is initiated via tube feeding to surpass the portion of the digestive tract most affected by secreted pancreatic enzymes if there is no improvement in the first 72–96 hours of treatment.[38]

Prognosis

Severe acute pancreatitis has mortality rates around 2–9%, higher where necrosis of the pancreas has occurred.[39]

Several scoring systems are used to predict the severity of an attack of pancreatitis. They each combine demographic and laboratory data to estimate severity or probability of death. Examples include APACHE II, Ranson, BISAP, and Glasgow. The Modified Glasgow criteria suggests that a case be considered severe if at least three of the following are true:[40]

This can be remembered using the mnemonic PANCREAS:

The BISAP score (blood urea nitrogen level >25 mg/dL (8.9 mmol/L), impaired mental status, systemic inflammatory response syndrome, age over 60 years, pleural effusion) has been validated as similar to other prognostic scoring systems.[41]

Epidemiology

Globally the incidence of acute pancreatitis is 5 to 35 cases per 100,000 people. The incidence of chronic pancreatitis is 4–8 per 100,000 with a prevalence of 26–42 cases per 100,000.[42] In 2013 pancreatitis resulted in 123,000 deaths up from 83,000 deaths in 1990.[7]

Costs

In adults in the United Kingdom, the estimated average total direct and indirect costs of chronic pancreatitis is roughly £79,000 per person on an annual basis.[43] Acute recurrent pancreatitis and chronic pancreatitis occur infrequently in children, but are associated with high healthcare costs due to substantial disease burden. Globally, the estimated average total cost of treatment for children with these conditions is approximately $40,500/person/year.[44]

Other animals

Fatty foods may cause canine pancreatitis in dogs.[45]

See also

External links

Notes and References

  1. News: Patient Care & Health Information > Diseases & Conditions: Pancreatitis . . 4 June 2022.
  2. Witt H, Apte MV, Keim V, Wilson JS . Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy . Gastroenterology . 132 . 4 . 1557–73 . April 2007 . 17466744 . 10.1053/j.gastro.2007.03.001 . free .
  3. Web site: Pancreatitis. niddk.nih.gov. 1 March 2015. August 16, 2012. live. https://web.archive.org/web/20150307095945/http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/pancreatitis/Pages/facts.aspx. 7 March 2015.
  4. Yadav D, Lowenfels AB . The epidemiology of pancreatitis and pancreatic cancer . Gastroenterology . 144 . 6 . 1252–61 . June 2013 . 23622135 . 3662544 . 10.1053/j.gastro.2013.01.068 .
  5. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . Lancet . 388 . 10053 . 1545–1602 . October 2016 . 27733282 . 5055577 . 10.1016/S0140-6736(16)31678-6 . Vos . Theo . Allen . Christine . Arora . Megha . Barber . Ryan M. . Bhutta . Zulfiqar A. . Brown . Alexandria . Carter . Austin . Casey . Daniel C. . Charlson . Fiona J. . Chen . Alan Z. . Coggeshall . Megan . Cornaby . Leslie . Dandona . Lalit . Dicker . Daniel J. . Dilegge . Tina . Erskine . Holly E. . Ferrari . Alize J. . Fitzmaurice . Christina . Fleming . Tom . Forouzanfar . Mohammad H. . Fullman . Nancy . Gething . Peter W. . Goldberg . Ellen M. . Graetz . Nicholas . Haagsma . Juanita A. . Hay . Simon I. . Johnson . Catherine O. . Kassebaum . Nicholas J. . Kawashima . Toana . Kemmer . Laura . 1 .
  6. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 . Lancet . 388 . 10053 . 1459–1544 . October 2016 . 27733281 . 5388903 . 10.1016/s0140-6736(16)31012-1 . Wang . Haidong . Naghavi . Mohsen . Allen . Christine . Barber . Ryan M. . Bhutta . Zulfiqar A. . Carter . Austin . Casey . Daniel C. . Charlson . Fiona J. . Chen . Alan Zian . Coates . Matthew M. . Coggeshall . Megan . Dandona . Lalit . Dicker . Daniel J. . Erskine . Holly E. . Ferrari . Alize J. . Fitzmaurice . Christina . Foreman . Kyle . Forouzanfar . Mohammad H. . Fraser . Maya S. . Fullman . Nancy . Gething . Peter W. . Goldberg . Ellen M. . Graetz . Nicholas . Haagsma . Juanita A. . Hay . Simon I. . Huynh . Chantal . Johnson . Catherine O. . Kassebaum . Nicholas J. . Kinfu . Yohannes . Kulikoff . Xie Rachel . 1 .
  7. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 . Lancet . 385 . 9963 . 117–71 . January 2015 . 25530442 . 4340604 . 10.1016/S0140-6736(14)61682-2 . ((GBD 2013 Mortality Causes of Death Collaborators)).
  8. Lankisch PG, Apte M, Banks PA . Acute pancreatitis . Lancet . 386 . 9988 . 85–96 . July 2015 . 25616312 . 10.1016/S0140-6736(14)60649-8 . 25600369 .
  9. Muniraj T, Aslanian HR, Farrell J, Jamidar PA . Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features . Disease-a-Month . 60 . 12 . 530–50 . December 2014 . 25510320 . 10.1016/j.disamonth.2014.11.002 .
  10. Fitzgerald JE, Gupta S, Masterson S, Sigurdsson HH . Laparostomy management using the ABThera™ open abdomen negative pressure therapy system in a grade IV open abdomen secondary to acute pancreatitis . International Wound Journal . 10 . 2 . 138–44 . April 2013 . 22487377 . 10.1111/j.1742-481X.2012.00953.x . 2459785 . 7950789 .
  11. Web site: NIDDK . Pancreatitis . July 2008 . National Digestive Diseases Information Clearinghouse . U.S. National Institute of Diabetes and Digestive and Kidney Diseases . 08–1596 . https://web.archive.org/web/20070107120906/http://digestive.niddk.nih.gov/ddiseases/pubs/pancreatitis/ . 2007-01-07 . 2007-01-05 .
  12. Web site: Pancreatitis . A.D.A.M., Inc. . 2013-01-05 . live . https://web.archive.org/web/20121230085927/http://www.umm.edu/altmed/articles/pancreatitis-000122.htm . 2012-12-30 .
  13. Apte MV, Pirola RC, Wilson JS . Pancreas: alcoholic pancreatitis—it's the alcohol, stupid . Nature Reviews. Gastroenterology & Hepatology . 6 . 6 . 321–2 . June 2009 . 19494819 . 10.1038/nrgastro.2009.84 . 6580794.
  14. Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lawrence C, Elinoff B, Greer JB, O'Connell M, Barmada MM, Slivka A, Whitcomb DC . 6 . Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis . Archives of Internal Medicine . 169 . 11 . 1035–45 . June 2009 . 19506173 . 6785300 . 10.1001/archinternmed.2009.125 .
  15. Web site: Pancreatitis Explained . 2011 . Better Health Channel . State Government of Victoria . https://web.archive.org/web/20100513082527/http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Pancreatitis_explained?OpenDocument . 2010-05-13 .
  16. Johnson CD, Hosking S . National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960–88 . Gut . 32 . 11 . 1401–5 . November 1991 . 1752477 . 1379177 . 10.1136/gut.32.11.1401 .
  17. Rawla P, Sunkara T, Thandra KC, Gaduputi V . Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies . Clinical Journal of Gastroenterology . 11 . 6 . 441–448 . December 2018 . 29923163 . 10.1007/s12328-018-0881-1 . 49311482 .
  18. Kaurich T . Drug-induced acute pancreatitis . Proceedings . 21 . 1 . 77–81 . January 2008 . 18209761 . 2190558 . 10.1080/08998280.2008.11928366 .
  19. Jones MR, Hall OM, Kaye AM, Kaye AD . Drug-induced acute pancreatitis: a review . The Ochsner Journal . 15 . 1 . 45–51 . 2015 . 25829880 . 4365846 . "Various oral hypoglycemic agents used in the treatment of diabetes are linked to acute pancreatitis. While some association exists between the occurrence of pancreatitis and biguanide agents such as metformin, as well as with dipeptidyl peptidase 4 inhibitors, including sitagliptin, vildagliptin, and saxagliptin, current research suggests that the only oral hypoglycemic agents with a disproportionately increased risk of pancreatitis are the glucagon-like peptide-1 (GLP-1) mimetics. Of particular concern is exenatide that was linked to 36 postmarketing reports of acute pancreatitis soon after its introduction. Further inquiry has estimated a 6-fold increase in the risk of pancreatitis with the use of exenatide compared to other therapies. The pathogenesis of GLP-1 analog-induced pancreatitis is unclear, but current evidence suggests an additive or synergistic exacerbation of pancreatitis when GLP-1 analogs are used in the presence of a high fat diet. The sequence of injury appears to begin with acinar cell hypertrophy, progress to proinflammatory cytokine induction, and culminate in pancreatic vascular injury" .
  20. Koller EA, Cross JT, Doraiswamy PM, Malozowski SN . Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports . Pharmacotherapy . 23 . 9 . 1123–30 . September 2003 . 14524644 . 10.1592/phco.23.10.1123.32759 . live . 39945446 . https://web.archive.org/web/20110208222922/http://www.medscape.com/viewarticle/461398_3 . 2011-02-08 .
  21. Rawla P, Bandaru SS, Vellipuram AR . Review of Infectious Etiology of Acute Pancreatitis . Gastroenterology Research . 10 . 3 . 153–158 . June 2017 . 28725301 . 5505279 . 10.14740/gr858w .
  22. Parenti DM, Steinberg W, Kang P . Infectious causes of acute pancreatitis . Pancreas . 13 . 4 . 356–71 . November 1996 . 8899796 . 10.1097/00006676-199611000-00005 .
  23. Economou M, Zissis M . Infectious cases of acute pancreatitis. Annals of Gastroenterology. 2000. 13. 2. 98–101. 22 November 2017. https://web.archive.org/web/20170809111554/http://www.annalsgastro.gr/files/journals/1/articlessos/4/submission/editor/4-16-1-ED.pdf. 2017-08-09.
  24. Noel RA, Braun DK, Patterson RE, Bloomgren GL . Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study . Diabetes Care . 32 . 5 . 834–8 . May 2009 . 19208917 . 2671118 . 10.2337/dc08-1755 . live . https://web.archive.org/web/20120610163642/http://care.diabetesjournals.org/content/32/5/834.full . 2012-06-10 .
  25. Macaluso JN . Editorial Comment . J. Urol. . 158 . 2 . 522 . August 1997 . 10.1016/S0022-5347(01)64525-7. on Matthews K, Correa RJ, Gibbons RP, Weissman RM, Kozarek RA . Extracorporeal shock wave lithotripsy for obstructing pancreatic duct calculi . The Journal of Urology . 158 . 2 . 522–5 . August 1997 . 9224338 . 10.1016/s0022-5347(01)64524-5 .
  26. Web site: Whitcomb D . 2006. Genetic Testing for Pancreatitis. https://web.archive.org/web/20171016070051/http://www.touchalimentarydisease.com/articles.cfm?article_id=6374&level=2. 2017-10-16.
  27. Web site: Causes of pancreatitis (mnemonic). Radiopaedia.org . 26 June 2021.
  28. Web site: Clinical manifestations and diagnosis of acute pancreatitis. www.uptodate.com. 2015-12-08. live. https://web.archive.org/web/20151208191308/http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-pancreatitis. 2015-12-08.
  29. Book: Greenberger NJ, Wu B, Conwell D, Banks P . Chronic Pancreatitis . Gastroenterology, Hepatology, & Endoscopy . . 301.
  30. Book: Tierney LW, McPhee SJ . Medicine . McGraw-Hill . 978-0071444415 . 2005-02-16 . registration .
  31. Book: Hospitalist Handbook. 4th. Department of Medicine University of California, San Francisco. 2012. 224–25.
  32. Türkvatan . A. . Erden . A. . Türkoğlu . M. A. . Seçil . M. . Yener . Ö. . 2015-02-01 . Imaging of acute pancreatitis and its complications. Part 1: Acute pancreatitis . Diagnostic and Interventional Imaging . 96 . 2 . 151–160 . 10.1016/j.diii.2013.12.017 . 2211-5684. free . 24512896 .
  33. Helm JF, Venu RP, Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Arndorfer RC . Effects of morphine on the human sphincter of Oddi . Gut . 29 . 10 . 1402–7 . October 1988 . 3197985 . 1434014 . 10.1136/gut.29.10.1402 .
  34. Vaughn VM, Shuster D, Rogers MA, Mann J, Conte ML, Saint S, Chopra V . Early Versus Delayed Feeding in Patients With Acute Pancreatitis: A Systematic Review . Annals of Internal Medicine . 166 . 12 . 883–892 . June 2017 . 28505667 . 10.7326/M16-2533 . 2025443 .
  35. Moody N, Adiamah A, Yanni F, Gomez D . Meta-analysis of randomized clinical trials of early versus delayed cholecystectomy for mild gallstone pancreatitis . The British Journal of Surgery . 106 . 11 . 1442–1451 . October 2019 . 31268184 . 10.1002/bjs.11221 . 195787962 .
  36. Web site: E Medicine Health . Balentine JR, Stöppler MC . Symptoms and Signs of Acute and Chronic Pancreatitis Differences .
  37. Li JY, Yu T, Chen GC, Yuan YH, Zhong W, Zhao LN, Chen QK . Enteral nutrition within 48 hours of admission improves clinical outcomes of acute pancreatitis by reducing complications: a meta-analysis . PLOS ONE . 8 . 6 . e64926 . Jun 6, 2013 . 23762266 . 3675100 . 10.1371/journal.pone.0064926 . 2013PLoSO...864926L . free .
  38. Muddana V, Whitcomb DC, Papachristou GI . Current management and novel insights in acute pancreatitis . Expert Review of Gastroenterology & Hepatology . 3 . 4 . 435–44 . August 2009 . 19673630 . 10.1586/egh.09.27 . 207210094 .
  39. Munoz A, Katerndahl DA . Diagnosis and management of acute pancreatitis . American Family Physician . 62 . 1 . 164–74 . July 2000 . 10905786 . live . https://web.archive.org/web/20121008115632/http://www.aafp.org/afp/2000/0701/p164.html . 2012-10-08 .
  40. Corfield AP, Cooper MJ, Williamson RC, Mayer AD, McMahon MJ, Dickson AP, Shearer MG, Imrie CW . 6 . Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices . Lancet . 2 . 8452 . 403–7 . August 1985 . 2863441 . 10.1016/S0140-6736(85)92733-3 . 46327341 .
  41. Papachristou GI, Muddana V, Yadav D, O'Connell M, Sanders MK, Slivka A, Whitcomb DC . Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis . The American Journal of Gastroenterology . 105 . 2 . 435–41; quiz 442 . February 2010 . 19861954 . 10.1038/ajg.2009.622 . 41655611 .
  42. Book: Harrison's Principles of Internal Medicine. 978-0071802161. 2015. 19th. Chapter 370 Approach to the Patient with Pancreatic Disease. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J . McGraw Hill Professional .
  43. Hall TC, Garcea G, Webb MA, Al-Leswas D, Metcalfe MS, Dennison AR . The socio-economic impact of chronic pancreatitis: a systematic review . Journal of Evaluation in Clinical Practice . 20 . 3 . 203–7 . June 2014 . 24661411 . 10.1111/jep.12117 .
  44. Ting J, Wilson L, Schwarzenberg SJ, Himes R, Barth B, Bellin MD, Durie PR, Fishman DS, Freedman SD, Gariepy CE, Giefer MJ, Gonska T, Husain SZ, Kumar S, Morinville VD, Lowe ME, Ooi CY, Pohl JF, Troendle D, Usatin D, Werlin SL, Wilschanski M, Heyman MB, Uc A . 6 . Direct Costs of Acute Recurrent and Chronic Pancreatitis in Children in the INSPPIRE Registry . Journal of Pediatric Gastroenterology and Nutrition . 62 . 3 . 443–9 . March 2016 . 26704866 . 4767646 . 10.1097/MPG.0000000000001057 .
  45. Web site: 8 Toxic Foods for Dogs. Calderone J . July 30, 2016. Consumer Reports. live. https://web.archive.org/web/20170211155407/http://www.consumerreports.org/pet-products/toxic-foods-for-dogs/. February 11, 2017.